Cargando…
Levofloxacin prophylaxis vs no prophylaxis in patients with neutropenia within an endemic country for carbapenem-resistant GNB
Fluoroquinolone prophylaxis’s (FQ-P) usefulness in patients with neutropenia is controversial. In recent decades, Italian epidemiological data has shown worrisome rates of FQ resistance. A single-center cohort study on 136 autologous stem cell transplantations (ASCTs) and 223 allogeneic hematopoieti...
Autores principales: | Clerici, Daniela, Galli, Laura, Greco, Raffaella, Lugli, Anna P., Erbella, Federico, Ripa, Marco, Tassan Din, Chiara, Nitti, Rosamaria, Giglio, Fabio, Mastaglio, Sara, Lorentino, Francesca, Xue, Elisabetta, Farina, Francesca, Liberatore, Carmine, Poli, Andrea, Carletti, Silvia, Lupo Stanghellini, Maria T., Carrabba, Matteo G., Assanelli, Andrea A., Ruggeri, Annalisa, Bernardi, Massimo, Corti, Consuelo, Peccatori, Jacopo, Mancini, Nicasio, Scarpellini, Paolo, Ciceri, Fabio, Castagna, Antonella, Oltolini, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182274/ https://www.ncbi.nlm.nih.gov/pubmed/36409602 http://dx.doi.org/10.1182/bloodadvances.2022008226 |
Ejemplares similares
-
Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis
por: Ardizzoia, Federica, et al.
Publicado: (2022) -
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation
por: Lorentino, Francesca, et al.
Publicado: (2022) -
Nanosphere's Verigene(®) Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
por: Greco, Raffaella, et al.
Publicado: (2019) -
Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation
por: Giglio, Fabio, et al.
Publicado: (2022) -
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
por: Greco, Raffaella, et al.
Publicado: (2019)